1
|
Shareghi-Boroujeni D, Iraji A, Dara M, Hashempur MH, Zare S, Hariri R, Akbarzadeh T, Saeedi M. Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes. Future Med Chem 2024:1-17. [PMID: 38864182 DOI: 10.1080/17568919.2024.2359894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2024] [Accepted: 05/13/2024] [Indexed: 06/13/2024] Open
Abstract
Aim: A new series of 1,2,3-triazole-hydrazone derivatives were developed to evaluate their anti-Alzheimer's activity. Materials & methods: All compounds were screened toward cholinesterases via the modified Ellman's method. The toxicity assay on SH-SY5Y cells was performed using the MTT assay, and the expression levels of GSK-3α, GSK-3β, DYRK1 and CDK5 were assessed in the presence of compounds 6m and 6p. Results: 6m and 6p; acting as mixed-type inhibitors, exhibited promising acetylcholinesterase and butyrylcholinesterase inhibitory activity, respectively. 6m demonstrated no toxicity under tested concentrations on the SH-SY5Y cells and positively impacted neurodegenerative pathways. Notably, 6m displayed a significant downregulation in mRNA levels of GSK-3α, GSK-3β and CDK5. Conclusion: The target compounds could be considered in developing anti-Alzheimer's disease agents.
Collapse
Affiliation(s)
- Diba Shareghi-Boroujeni
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Aida Iraji
- Research Center for Traditional Medicine & History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
- Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mahintaj Dara
- Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammad Hashem Hashempur
- Research Center for Traditional Medicine & History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Shahrokh Zare
- Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Roshanak Hariri
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Tahmineh Akbarzadeh
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- Persian Medicine & Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Mina Saeedi
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- Persian Medicine & Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Manayi A, Rastegari A, Heydarian B, Vahedi-Mazdabadi Y, Khanavi M, Akbarzadeh T, Saeedi M. Phytochemical investigation and biological activity of Doronicum pardalianches L. roots against Alzheimer's disease. Nat Prod Res 2023; 37:1227-1231. [PMID: 34727787 DOI: 10.1080/14786419.2021.1999944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
The methanol extract of Doronicum pardalianches L. was fractionated using n-hexane, chloroform, and ethyl acetate to evaluate their cholinesterase (ChE) inhibitory activity via modified Ellman's method. It was perceived that only the ethyl acetate fraction was active toward acetylcholinesterase (AChE) with IC50 value of 172.21 µg/mL. Also, all fractions showed no butyrylcholinesterase (BChE) inhibitory activity. The ethyl acetate fraction was also investigated for its neuroprotectivity and metal chelating ability (Zn2+, Fe2+, and Cu2+) which demonstrated desired activity. Phytochemical analysis of the ethyl acetate fraction led to isolation and identification of formononetin 7-O-β-D-glucopyranoside which has not been previously reported for this plant.
Collapse
Affiliation(s)
- Azadeh Manayi
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Arezoo Rastegari
- Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Bita Heydarian
- Faculty of Pharmacy, Department of Medicinal Chemistry, Tehran University of Medical Sciences, Tehran, Iran
| | - Yasaman Vahedi-Mazdabadi
- Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Mahnaz Khanavi
- Faculty of Pharmacy, Department of Pharmacognosy, Tehran University of Medical Sciences, Tehran, Iran
| | - Tahmineh Akbarzadeh
- Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran.,Faculty of Pharmacy, Department of Medicinal Chemistry, Tehran University of Medical Sciences, Tehran, Iran
| | - Mina Saeedi
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.,Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
3
|
Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer's disease therapy. Future Med Chem 2022; 14:1583-1606. [PMID: 36263996 DOI: 10.4155/fmc-2022-0170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Among neurodegenerative pathologies affecting the older population, Alzheimer's disease is the most common type of dementia and leads to neurocognitive and behavioral disorders. It is a complex and progressive age-related multifactorial disease characterized by a series of highly interconnected pathophysiological processes. Within the last decade, the multitarget-directed ligand strategy has emerged as a viable approach to developing complex molecules that exhibit several pharmacophores which can target the different enzymes and receptors involved in the pathogenesis of the disease. Herein, we focus on using multicomponent reactions such as Hantzsch, Biginelli and Ugi to develop these biologically active multitopic ligands.
Collapse
|
4
|
Chehardoli G, Gholamhoseini P, Ebadi A, Ziaei M, Akbarzadeh T, Saeedi M, Mahdavi M, Khoshneviszadeh M, Najafi Z. 6‐Methoxy‐1‐tetralone Derivatives Bearing an N‐Arylpyridinium Moiety as Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Molecular Docking Study. ChemistrySelect 2022. [DOI: 10.1002/slct.202201977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Gholamabbas Chehardoli
- Department of Medicinal Chemistry School of Pharmacy Medicinal Plants and Natural Products Research Center Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran
| | - Pooriya Gholamhoseini
- Department of Medicinal Chemistry School of Pharmacy Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran
| | - Ahmad Ebadi
- Department of Medicinal Chemistry School of Pharmacy Medicinal Plants and Natural Products Research Center Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran
| | - Maral Ziaei
- Department of Medicinal Chemistry School of Pharmacy Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran
| | - Tahmineh Akbarzadeh
- Department of Medicinal Chemistry Faculty of Pharmacy Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran
- Persian Medicine and Pharmacy Research Center Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran
| | - Mina Saeedi
- Persian Medicine and Pharmacy Research Center Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran
- Medicinal Plants Research Center, Faculty of Pharmacy Tehran University of Medical Sciences 16 Azar Street 1417614411 Tehran Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences 1411713137 Tehran Iran
| | - Mehdi Khoshneviszadeh
- Department of Medicinal Chemistry Faculty of Pharmacy Shiraz University of Medical Sciences 7146864685 Shiraz Iran
| | - Zahra Najafi
- Department of Medicinal Chemistry School of Pharmacy Hamadan University of Medical Sciences Shahid Fahmideh Street 6517838678 Hamadan Iran
| |
Collapse
|
5
|
Silalai P, Jaipea S, Tocharus J, Athipornchai A, Suksamrarn A, Saeeng R. New 1,2,3-Triazole-genipin Analogues and Their Anti-Alzheimer's Activity. ACS OMEGA 2022; 7:24302-24316. [PMID: 35874205 PMCID: PMC9301951 DOI: 10.1021/acsomega.2c01593] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
A novel series of 1,2,3-triazole-genipin analogues were designed, synthesized, and evaluated for neuroprotective activity, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE) inhibitory activity. The genipin analogues bearing bromoethyl- and diphenylhydroxy-triazole showed in vitro neuroprotective properties against H2O2 toxicity along with potent inhibitory activity on BuChE with IC50 values of 31.77 and 54.33 μM, respectively, compared with galantamine (IC50 = 34.05 μM). The molecular docking studies of these genipin analogues showed good binding energy and interact well with the key amino acids of BuChE via hydrogen-bonding and hydrophobic interactions. Triazole genipins might be promising lead compounds as anti-Alzheimer's agents.
Collapse
Affiliation(s)
- Patamawadee Silalai
- Department
of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand
| | - Suwichada Jaipea
- Department
of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand
| | - Jiraporn Tocharus
- Department
of Physiology, Faculty of Medicine, Chiang
Mai University, Chiang
Mai 50200, Thailand
| | - Anan Athipornchai
- Department
of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand
| | - Apichart Suksamrarn
- Department
of Chemistry and Center of Excellence for Innovation in Chemistry,
Faculty of Science, Ramkhamhaeng University, Bangkok 10240, Thailand
| | - Rungnapha Saeeng
- Department
of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand
- The
Research Unit in Synthetic Compounds and Synthetic Analogues from
Natural Product for Drug Discovery (RSND), Burapha University, Chonburi 20131, Thailand
| |
Collapse
|
6
|
Saldívar-González FI, Huerta-García CS, Medina-Franco JL. Chemoinformatics-based enumeration of chemical libraries: a tutorial. J Cheminform 2020; 12:64. [PMID: 33372622 PMCID: PMC7590480 DOI: 10.1186/s13321-020-00466-z] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Accepted: 10/05/2020] [Indexed: 11/10/2022] Open
Abstract
Virtual compound libraries are increasingly being used in computer-assisted drug discovery applications and have led to numerous successful cases. This paper aims to examine the fundamental concepts of library design and describe how to enumerate virtual libraries using open source tools. To exemplify the enumeration of chemical libraries, we emphasize the use of pre-validated or reported reactions and accessible chemical reagents. This tutorial shows a step-by-step procedure for anyone interested in designing and building chemical libraries with or without chemoinformatics experience. The aim is to explore various methodologies proposed by synthetic organic chemists and explore affordable chemical space using open-access chemoinformatics tools. As part of the tutorial, we discuss three examples of design: a Diversity-Oriented-Synthesis library based on lactams, a bis-heterocyclic combinatorial library, and a set of target-oriented molecules: isoindolinone based compounds as potential acetylcholinesterase inhibitors. This manuscript also seeks to contribute to the critical task of teaching and learning chemoinformatics.
Collapse
Affiliation(s)
- Fernanda I. Saldívar-González
- DIFACQUIM Research Group, School of Chemistry, Department of Pharmacy, Universidad Nacional Autónoma de México, Avenida Universidad 3000, 04510 Mexico, Mexico
| | - C. Sebastian Huerta-García
- School of Chemistry, Department of Pharmacy, Universidad Nacional Autónoma de México, Avenida Universidad 3000, 04510 Mexico, Mexico
| | - José L. Medina-Franco
- DIFACQUIM Research Group, School of Chemistry, Department of Pharmacy, Universidad Nacional Autónoma de México, Avenida Universidad 3000, 04510 Mexico, Mexico
| |
Collapse
|
7
|
Saeedi M, Safavi M, Allahabadi E, Rastegari A, Hariri R, Jafari S, Bukhari SNA, Mirfazli SS, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T. Thieno[2,3-b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease. Arch Pharm (Weinheim) 2020; 353:e2000101. [PMID: 32657467 DOI: 10.1002/ardp.202000101] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Revised: 06/10/2020] [Accepted: 06/15/2020] [Indexed: 11/06/2022]
Abstract
In search of safer tacrine analogs, various thieno[2,3-b]pyridine amine derivatives were synthesized and evaluated for their inhibitory activity against cholinesterases (ChEs). Among the synthesized compounds, compounds 5e and 5d showed the highest activity towards acetylcholinesterase and butyrylcholinesterase, with IC50 values of 1.55 and 0.23 µM, respectively. The most active ChE inhibitors (5e and 5d) were also candidates for further complementary assays, such as kinetic and molecular docking studies as well as studies on inhibitory activity towards amyloid-beta (βA) aggregation and β-secretase 1, neuroprotectivity, and cytotoxicity against HepG2 cells. Our results indicated efficient anti-Alzheimer's activity of the synthesized compounds.
Collapse
Affiliation(s)
- Mina Saeedi
- Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.,Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Maliheh Safavi
- Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran
| | - Emad Allahabadi
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Arezoo Rastegari
- Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Roshanak Hariri
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Sanaz Jafari
- Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran
| | - Syed N A Bukhari
- Department of Pharmaceutical Chemistry, College of Pharmacy, Aljouf University, Aljouf, Saudi Arabia
| | - Seyedeh S Mirfazli
- Department of Medicinal Chemistry, Iran University of Medical Sciences, Tehran, Iran
| | - Omidreza Firuzi
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Najmeh Edraki
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammad Mahdavi
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Tahmineh Akbarzadeh
- Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran.,Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
8
|
Synthesis, biological evaluation and modeling of hybrids from tetrahydro-1H-pyrazolo[3,4-b]quinolines as dual cholinestrase and COX-2 inhibitors. Bioorg Chem 2020; 100:103895. [DOI: 10.1016/j.bioorg.2020.103895] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 04/19/2020] [Accepted: 04/28/2020] [Indexed: 12/27/2022]
|
9
|
Shaabani A, Mohammadian R, Afshari R, Hooshmand SE, Nazeri MT, Javanbakht S. The status of isocyanide-based multi-component reactions in Iran (2010-2018). Mol Divers 2020; 25:1145-1210. [PMID: 32072381 DOI: 10.1007/s11030-020-10049-7] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2019] [Accepted: 02/06/2020] [Indexed: 11/30/2022]
Abstract
Isocyanides as key intermediates and magic reactants have been widely applied in organic reactions for direct access to a broad spectrum of remarkable organic compounds. Although the history of these magical compounds dates back more than 100 years, it still has been drawing widespread attention of chemists who confirmed their versatility and effectiveness. Because of their wide spectrum of pharmacological, industrial and synthetic applications, many reactions with the utilization of isocyanides are reported in the literature. In this context, Iranian scientist played a significant role in the growth of isocyanides chemistry. The present review article covers literature from the period starting from 2010 onward and encompasses new synthetic routes and organic transformation involving isocyanides by Iranian researchers. During this period, a diverse range of isocyanide-based multi-component reactions (I-MCRs) has been reported such as a new modification of Ugi, post-Ugi, Passerini and Groebke-Blackburn-Bienayme condensation reactions, isocyanide-based [1 + 4] cycloaddition reactions, isocyanide-acetylene-based MCRs, isocyanide and Meldrum's acid-based MCRs, several unexpected reactions besides green mediums and novel catalytic systems for the synthesis of diverse kinds of pharmaceutically and industrially remarkable heterocyclic and linear organic compounds. This review also emphasizes the neoteric applications of I-MCR for the synthesis of valuable peptide and pseudopeptide scaffolds, enzyme immobilization and functionalization of materials with tailorable properties that can play important roles in the plethora of applications.
Collapse
Affiliation(s)
- Ahmad Shaabani
- Faculty of Chemistry, Shahid Beheshti University, Daneshjou Boulevard, Tehran, 19396-4716, Iran.
| | - Reza Mohammadian
- Faculty of Chemistry, Shahid Beheshti University, Daneshjou Boulevard, Tehran, 19396-4716, Iran
| | - Ronak Afshari
- Faculty of Chemistry, Shahid Beheshti University, Daneshjou Boulevard, Tehran, 19396-4716, Iran
| | - Seyyed Emad Hooshmand
- Faculty of Chemistry, Shahid Beheshti University, Daneshjou Boulevard, Tehran, 19396-4716, Iran
| | - Mohammad Taghi Nazeri
- Faculty of Chemistry, Shahid Beheshti University, Daneshjou Boulevard, Tehran, 19396-4716, Iran
| | - Siamak Javanbakht
- Faculty of Chemistry, Shahid Beheshti University, Daneshjou Boulevard, Tehran, 19396-4716, Iran
| |
Collapse
|
10
|
Mollazadeh M, Mohammadi-Khanaposhtani M, Zonouzi A, Nadri H, Najafi Z, Larijani B, Mahdavi M. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer’s disease: Design, synthesis, biological evaluation, and docking study. Bioorg Chem 2019; 87:506-515. [DOI: 10.1016/j.bioorg.2019.03.012] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2018] [Revised: 03/04/2019] [Accepted: 03/05/2019] [Indexed: 12/22/2022]
|
11
|
Ragab HM, Teleb M, Haidar HR, Gouda N. Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer's disease. Bioorg Chem 2019; 86:557-568. [PMID: 30782574 DOI: 10.1016/j.bioorg.2019.02.033] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2018] [Revised: 02/13/2019] [Accepted: 02/13/2019] [Indexed: 12/13/2022]
Abstract
In search of potent acetyl cholinesterase inhibitors with low hepatotoxicity for the treatment of Alzheimer's disease, introduction of a chloro substitution to tacrine and some of its analogs has proven to be beneficial in maintaining or potentiating the cholinesterase inhibitory activity. Furthermore, it was found to be able to reduce the hepatotoxicity of the synthesized compounds, which is the main target of the study. Accordingly, a series of new 4-(chlorophenyl)tetrahydroquinoline derivatives, was synthesized and characterized. The synthesized compounds were evaluated for their in vitro and in vivo anti-cholinesterase activity using tacrine as a reference standard. Furthermore, they were investigated for their hepatotoxicity compared to tacrine. The obtained biological results revealed that all synthesized compounds displayed equivalent or significantly higher anti-cholinesterase activity and lower hepatotoxicity in comparison to tacrine. In addition, in silico drug-likeness of the synthesized compounds were predicted and their practical logP were assessed indicating that all synthesized compounds can be considered as promising hits/leads. Furthermore, docking study of the compound showing the highest in vitro anticholinesterase activity was performed and its binding mode was compared to that of tacrine.
Collapse
Affiliation(s)
- Hanan M Ragab
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
| | - Mohamed Teleb
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt
| | - Hassan R Haidar
- Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
| | - Noha Gouda
- Noha Gouda, Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt
| |
Collapse
|
12
|
Bahadorikhalili S, Mahdavi M, Ma’mani L, Shafiee A, Mahdavi H, Akbarzadeh T. Palladium functionalized phosphinite polyethyleneimine grafted magnetic silica nanoparticles as an efficient catalyst for the synthesis of isoquinolino[1,2-b]quinazolin-8-ones. NEW J CHEM 2018. [DOI: 10.1039/c7nj04837h] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Novel 5-methyl-8H-isoquinolino[1,2-b]quinazolin-8-one derivatives are synthesized using a reusable immobilized palladium catalyzed intramolecular carbon–carbon bond formation.
Collapse
Affiliation(s)
| | - Mohammad Mahdavi
- Endocrinology Metabolism Research Center
- Endocrinology Metabolism Clinical Sciences Institute
- Tehran University of Medical Science
- Tehran
- Iran
| | - Leila Ma’mani
- Department of Nanotechnology
- Agricultural Biotechnology Research Institute of Iran (ABRII)
- Agricultural Research
- Education and Extension Organization (AREEO)
- Karaj
| | - Abbas Shafiee
- Department of Medicinal Chemistry
- Faculty of Pharmacy
- Tehran University of Medical Sciences
- Tehran
- Iran
| | - Hossein Mahdavi
- School of Chemistry
- College of Science
- University of Tehran
- Tehran
- Iran
| | - Tahmineh Akbarzadeh
- Department of Medicinal Chemistry
- Faculty of Pharmacy
- Tehran University of Medical Sciences
- Tehran
- Iran
| |
Collapse
|
13
|
An efficient access to 2,3-diarylimidazo[1,2-a]pyridines via silver(I)-catalyzed C-H bond functionalization. MONATSHEFTE FUR CHEMIE 2017. [DOI: 10.1007/s00706-017-1950-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
14
|
Hariri R, Afshar Z, Mahdavi M, Safavi M, Saeedi M, Najafi Z, Sabourian R, Karimpour-Razkenari E, Edraki N, Moghadam FH, Shafiee A, Khanavi M, Akbarzadeh T. Novel Tacrine-Based Pyrano[3’,4’:5,6]pyrano[2,3-b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity. Arch Pharm (Weinheim) 2016; 349:915-924. [DOI: 10.1002/ardp.201600123] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2016] [Revised: 10/12/2016] [Accepted: 10/13/2016] [Indexed: 11/05/2022]
Affiliation(s)
- Roshanak Hariri
- Faculty of Pharmacy, Department of Medicinal Chemistry; Tehran University of Medical Sciences; Tehran Iran
| | - Zahra Afshar
- Faculty of Pharmacy, Department of Medicinal Chemistry; Tehran University of Medical Sciences; Tehran Iran
| | - Mohammad Mahdavi
- Drug Design and Development Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Maliheh Safavi
- Department of Biotechnology; Iranian Research Organization for Science and Technology; Tehran Iran
| | - Mina Saeedi
- Medicinal Plants Research Center; Faculty of Pharmacy; Tehran University of Medical Sciences; Tehran Iran
- Persian Medicine and Pharmacy Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Zahra Najafi
- Faculty of Pharmacy, Department of Medicinal Chemistry; Hamadan University of Medical Sciences; Hamadan Iran
| | - Reyhaneh Sabourian
- Persian Medicine and Pharmacy Research Center; Tehran University of Medical Sciences; Tehran Iran
| | | | - Najmeh Edraki
- Medicinal and Natural Products Chemistry Research Center; Shiraz University of Medical Sciences; Shiraz Iran
| | - Farshad Homayouni Moghadam
- Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology; ACECR; Isfahan Iran
| | - Abbas Shafiee
- Faculty of Pharmacy, Department of Medicinal Chemistry; Tehran University of Medical Sciences; Tehran Iran
| | - Mahnaz Khanavi
- Faculty of Pharmacy, Department of Pharmacognosy; Tehran University of Medical Sciences; Tehran Iran
| | - Tahmineh Akbarzadeh
- Faculty of Pharmacy, Department of Medicinal Chemistry; Tehran University of Medical Sciences; Tehran Iran
- Persian Medicine and Pharmacy Research Center; Tehran University of Medical Sciences; Tehran Iran
| |
Collapse
|
15
|
Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids. Bioorg Chem 2016; 67:84-94. [DOI: 10.1016/j.bioorg.2016.06.001] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2016] [Revised: 05/31/2016] [Accepted: 06/01/2016] [Indexed: 11/24/2022]
|
16
|
Hetero-annulated coumarins as new AChE/BuChE inhibitors: synthesis and biological evaluation. Med Chem Res 2016. [DOI: 10.1007/s00044-016-1626-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Saeedi M, Golipoor M, Mahdavi M, Moradi A, Nadri H, Emami S, Foroumadi A, Shafiee A. Phthalimide-DerivedN-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents. Arch Pharm (Weinheim) 2016; 349:293-301. [DOI: 10.1002/ardp.201500425] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2015] [Revised: 01/28/2016] [Accepted: 02/01/2016] [Indexed: 12/15/2022]
Affiliation(s)
- Mina Saeedi
- Medicinal Plants Research Center, Faculty of Pharmacy; Tehran University of Medical Sciences; Tehran Iran
- Persian Medicine and Pharmacy Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Maedeh Golipoor
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Mohammad Mahdavi
- Drug Design and Development Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Alireza Moradi
- Faculty of Pharmacy, Department of Medicinal Chemistry; Shahid Sadoughi University of Medical Sciences; Yazd Iran
| | - Hamid Nadri
- Faculty of Pharmacy, Department of Medicinal Chemistry; Shahid Sadoughi University of Medical Sciences; Yazd Iran
| | - Saeed Emami
- Faculty of Pharmacy, Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center; Mazandaran University of Medical Sciences; Sari Iran
| | - Alireza Foroumadi
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran
| | - Abbas Shafiee
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medical Sciences; Tehran Iran
| |
Collapse
|
18
|
Chen T, Cai C. Sc(OTf)3-catalyzed three-component cascade reaction: One-pot synthesis of substituted 3-oxoisoindoline-1-carbonitrile derivatives. CATAL COMMUN 2016. [DOI: 10.1016/j.catcom.2015.11.011] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
|
19
|
Saeedi M, Ansari S, Mahdavi M, Sabourian R, Akbarzadeh T, Foroumadi A, Shafiee A. Synthesis of Novel 1,2,3-Triazole-dihydro[3,2-c]chromenones as Acetylcholinesterase Inhibitors. SYNTHETIC COMMUN 2015. [DOI: 10.1080/00397911.2015.1077971] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Dianat S, Mahdavi M, Moghimi S, Mouradzadegun A, Shafiee A, Foroumadi A. Combined isocyanide-based multi-component Ullmann-type reaction: an efficient access to novel nitrogen-containing pentacyclic compounds. Mol Divers 2015; 19:797-805. [DOI: 10.1007/s11030-015-9622-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2015] [Accepted: 07/19/2015] [Indexed: 12/29/2022]
|